Solara Active Pharma Sciences share news, announcements and annual reports
NSE: SOLARABSE: 541540Pharmaceuticals & BiotechnologySmall Cap
Solara Active Pharma Sciences Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 2018
Last close ₹655.25up ₹1.45 (0.22%)BSE ₹654.95
Share price at the NSE close on 29 Oct 2026. Previous close ₹653.80.
29 Oct: open ₹650.00, high ₹662.30, low ₹646.75
52-week range of traded prices to 29 Oct 2026
₹422.00Low, 30 Mar 2026₹774.00High, 15 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,162 Cr1,182nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 85.59
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 66.80
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.20
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 2.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹10 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 3.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,08,38247.0% delivered
Solara Active Pharma Sciences disputes and clarifications
14 filed, newest first.
Jun 2026
10 Jun · Legal
The exchange asked on 9 Jun 2026
Mar 2026
Dec 2025
4 Dec · Legal
The exchange asked on 3 Dec 2025
Sep 2025
26 Sep · Legal
The exchange asked on 25 Sep 2025
Jul 2024
3 Jul · Legal
The exchange asked on 2 Jul 2024
Apr 2024
23 Apr · Legal
The exchange asked on 22 Apr 2024
Jun 2023
15 Jun · Legal
The exchange asked on 15 Jun 2023
Dec 2022
22 Dec · Legal
The exchange asked on 21 Dec 2022
Jun 2022
24 Jun · Legal
The exchange asked on 24 Jun 2022
Jan 2022
10 Jan · Legal
The exchange asked on 3 Jan 2022
Mar 2020
16 Mar · Legal
The exchange asked on 13 Mar 2020
Dec 2019
24 Dec · Legal
Exchange has sought clarification from Solara Active Pharma Sciences Limited with respect to announcement dated 19-Dec-2019, regarding change in Registrar and Share Transfer Agent of the Company from KFin Technologies Private Limited to Cameo Corporate Services Limited.On basis of above the Company is required to clarify following:1. Reason for appointment or discontinuation;The response of the Company is awaited.
Sep 2018